期刊文献+

经阴道三维能量多普勒超声定量分析卵巢肿块的良恶性 被引量:1

Quantitative Analysis of Malignant and Benign Ovarian Masses with Transvaginal Three- dimensional Power Doppler Ultrasound
下载PDF
导出
摘要 目的探讨经阴道三维能量多普勒超声(three-dimensional power Doppler transvaginal ultrasound,3DPD-TVS)定量分析卵巢肿块血流灌注参数并评估其鉴别卵巢肿块良恶性的价值.方法应用3DPD-TVS对101个卵巢肿块进行检查并测量以下参数:阻力指数(resistance index,RI)、血管化指数(vascularization index,VI)、血流指数(flow index,FI)、血管化血流指数(vascularization flow index,VFI),分析数据并与术后病理结果对照.结果卵巢肿块恶性组VI、FI、VFI值明显高于良性组[(1.57±2.37)vs(5.10±4.68)、(35.53±7.91)vs(40.92±6.82)、(0.61±0.99)vs(2.18±2.06)],差异有统计学意义(P<0.05);而2组间比较,RI无明显差异(P>0.05).结论经阴道三维能量多普勒超声能较客观定量分析卵巢肿块的血供情况,为鉴别卵巢肿块良恶性提供一定的参考价值. Objective To investigate the effect of three- dimensional power Doppler transvaginal ultrasound( 3DPD- TVS) quantitative analysis of ovarian masses perfusion parameters and evaluate the value of it in identification of the malignant and benign ovarian masses. Methods 101 ovarian masses were examined with3DPD- TVS and the corresponding parameters: the resistance index( RI), vascularization index( VI), flow index( FI),vascularization flow index( VFI) were analyzed. Then the results were compared with the postoperative pathological results.Results VI, FI, VFI values with ovarian malignant tumor group were significantly higher than those in benign tumor group, the difference was statistically significant( P〈0.05). RI showed no significant difference between malignant tumor group and benign masses group( P〈0.05).Conclusion Transvaginal three- dimensional power Doppler ultrasound can be used to objectively and quantitatively analyze of ovarian masses and provide certain reference value for the identification of malignant and benign ovarian masses.
出处 《昆明医科大学学报》 CAS 2016年第2期68-71,共4页 Journal of Kunming Medical University
基金 中国福利会科学研究基金资助项目(G2011089545)
关键词 经阴道 三维能量多普勒超声 卵巢肿块 良恶性 Transvagina Three-dimensional power doppler ultrasound Ovarian masses Benign and malignant
  • 相关文献

参考文献14

  • 1田扬顺,黄高升,王红英,陈必良,马向东,杨红,赛晓勇.卵巢肿瘤2668例分类及发病特点分析[J].中国妇产科临床杂志,2007,8(3):166-168. 被引量:8
  • 2OZDS R F,BOOKMANMA, CONNOLLYDC,et al. Focus on epithelial ovarian cancer[J]. Cancer Ce11,2004,5( 1 ) : 19-24.
  • 3FOLKMAN J. Tumor angiogenesis:therapeutic implica- tions [ J ]. N Engl J Med, 1971,285 (21 ) : 1 182- 1 186.
  • 4KURJAK A,KUPESIC S,SPARAC V,et al. The detec- tion of stage I ovarian cancer by three-dimensional sonog- raphy and power doppler [ J ]. GyneeolOncol,2003,90 (2) :258-264.
  • 5宋绿茵,史文静,张燕,郑彩银,付金枝.多普勒超声血流显像联合血清CA_(125)CA_(199)在卵巢恶性肿瘤诊断中的价值[J].中国实用妇科与产科杂志,2006,22(1):49-50. 被引量:12
  • 6GILEAD A, MEIR G, NEEMAN M. The role of angiogen- esis, vascular maturation, regression and stroma infiltration indormancy and growth of implanted MLS ovarian carcino- maspheroids [ J ].Int J Cancer, 2004, 108 (4) : 524- 531.
  • 7GIATROMANOLAKI A,SIVRIDIS E,TSIKOURAS P,et al. Angio-genesis and vascular survival ability in ovarian adenocarci-nomas [J]. Virchows Arch,2004,445 (5): 521 -526.
  • 8JOKUBKIENE J,SLADKEVICIUS P,VALENTIN I. Does three-dimensional power Doppler ultrasound help in dis- crimination between benign and malignant ovarianmasses [J]. Uhrasound ObstetGynecol, 2007,29(2) : 215- 225.
  • 9ALCAZAR J L, MERCE L T, GARCIA MANERO M G. Three-dimensional power Doppler vascular sonographic- sampling:a new method for predicting ovarian cancer in vaseularized complex adnexal masses [J]. J Ultrasound Med, 2005,24(5 ) : 689- 696.
  • 10BERRA E, MILANINI J, RICHARD D E,et al. Signaling angiogenesis via p42 / p44 MAP kinase and hypoxia [ J ]. BiochemPharmacol, 2000,60(8 ) : 1 171 - 1 178.

二级参考文献11

  • 1Matin L, Jeff B. Preoperative CA125 levels in patients with hereditary compared to sporadic epithelial ovarian carcinoma [ J ]. Gynecol Oncol, 2002,84 ( 5 ) :413-415.
  • 2McGuire WP. CA125 and early ovarian cancer: does this help the clinician or further muddy the water[J] ? J Clin Oncol, 2005,23 ( 25 ) :5862-5864.
  • 3Fioretti P, Gadducci A, Ferdeghini M, et al. The concomitant determination of different serum tumor markers in epithelial ovarian careimona, Relevance for monitoring the response to chemotherapy and follow up of patients [ J ]. Gynecol Oncol, 1992,44:155-157.
  • 4Yokoyama Y, Higuchi T, Mizunuma H. The potential and problems of screening for ovarian cancer[J]. Eur J Gynaecol Oncol,2005,26 ( 3 ) :241-243.
  • 5Fishman DA, Cohen L, Blank SV, et al. The role of uhrasound evaluation in the detection of early-stage epithelial ovarian cancer[J]. Am J Obstet Gynecol, 2005,192(4):1214-1222.
  • 6Kurjak A,Kupesic S.Three-dimensional ultrasound and power Doppler in assessment of uterine and ovarian angiogenesis:a prospective study.Croat Med J,1999,40:413-420.
  • 7Yoshino S,Kato M,Oktok,Prognostic significance of microvessel count in low stage renal cell carcinoma.Int J Urol,1995,2:156-160.
  • 8马水清,沈铿,郎景和.恶性肿瘤风险指数在卵巢恶性肿瘤术前诊断中的作用[J].中华妇产科杂志,2001,36(3):162-164. 被引量:33
  • 9赵玉珍,王月香,金瑞芳,纪晓惠,李英敏.卵巢肿瘤的三维彩色血管能量成像与病理微血管密度对比研究[J].中国超声医学杂志,2001,17(11):866-869. 被引量:27
  • 10石一复,叶大风,吕卫国,赵承洛,徐建云,陈利友.我国10288例卵巢恶性肿瘤的分布及组织学类型[J].中华妇产科杂志,2002,37(2):97-100. 被引量:39

共引文献37

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部